Medline ® Abstract for Reference 38
of 'Radiation therapy techniques for newly diagnosed, non-metastatic breast cancer'
Impact of boost technique on outcome in early-stage breast cancer patients treated with breast-conserving therapy.
Frazier RC, Kestin LL, Kini V, Martinez AA, Chen PY, Baglan KL, Vicini FA
Am J Clin Oncol. 2001;24(1):26.
We reviewed our institution's experience treating early-stage breast cancer patients with breast-conserving therapy (BCT) to determine the impact of boost technique on outcome. A total of 552 patients with stage I and II breast cancer were managed with BCT. All patients were treated with a partial mastectomy and radiation therapy (RT). RT consisted of 45 Gy to 50 Gy external beam irradiation to the whole breast followed by a boost to the tumor bed using either electrons (232 patients), photons (15 patients), or an interstitial implant (316 patients). Local control and cosmetic outcome was compared among three patient groups based on the type of boost used. Forty-one patients had a recurrence of cancer in the treated breast for 5-, 10-, and 13-year actuarial local recurrence rates of 2.8%, 7.5%, and 11.2%, respectively. There were no significant differences in the local recurrence rates or cosmetic outcome using electrons, photons, or an interstitial implant. On multivariate analysis, only young age and margin status were associated with local recurrence. Stage I and II breast cancer patients undergoing BCT can be effectively managed with electron, photon, or interstitial implant boost techniques. Long-term local control and cosmetic outcome are excellent regardless of which boost technique is used.
Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA.